Formalin-fixed, paraffin-embedded tissue blocks from 14 dogs were used to test the utility of a newly developed semi-nested reverse transcription polymerase chain reaction (RT-PCR) assay for canine distemper virus (CDV). The results from this new test were compared with those of histopathologic examination, fluorescent antibody detection (FA), and immunohistochemistry (IHC). The semi-nested RT-PCR protocol was used to detect CDV RNA in 9 of the 10 cases that were positive by at least 1 of the immunologic (FA and IHC) methods. Sequence data indicated that the amplified strains of CDV are more closely related to a naturally occurring strain than to a vaccine strain. Thus, the semi-nested RT-PCR assay is a useful diagnostic method applicable to the retrospective diagnosis of CDV infection. Sequence determination may yield molecular epidemiologic information regarding vaccine efficacy.
Canine distemper virus (CDV) is a member of the genus Morbillivirus, family Paramyxoviridae, which are negative-sense, single-stranded RNA viruses. 3 Canine distemper virus is a highly contagious pathogen with a worldwide distribution. 3, 7 Eradication of CDV is considered impossible because of the virus's wide host range, which includes terrestrial carnivores and marine mammals. 1, 3, 8, 14, 17, 19 Because of its pantropic nature, neurologic, respiratory, and integumentary disorders are among the many presentations of canine distemper infection. 21 Accurate diagnostic assays for CDV are of paramount importance considering its global distribution, its broad host range, its myriad of clinical presentations, its history of mass mortality events, 3, 7, 8, 17 and the availability of vaccines that may curtail local epizootics. 4 There are currently several techniques that can be used to test for CDV infection in dogs, including immunofluorescence, 5, 12 immunohistochemistry, 11, 15 and histopathologic analysis. 15, 21 However, each of these tests has limitations; immunofluorescence can only be performed on fresh-frozen tissue, immunohistochemistry is dependent on specific antibody-fixation parameters, and histopathology is not specific and requires a confirmatory test. Furthermore, none of these tests allow for genetic analysis. Consequently, the use of multiple tests may be the best diagnostic strategy, and it is important to develop new diagnostic assays that allow retrospective genetic analysis and maintain or improve detection limits.
Modern infectious disease diagnostic innovations include the development of nucleic acid-based assays, 6, 9, 16, 18 which amplify pathogen-specific nucleic acid, permitting the detection of fewer organisms and thereby increasing the probability of detecting the agent. Previous studies have shown that CDV RNA can be reverse transcribed and then amplified from whole blood, serum, cerebrospinal fluid, and formalinfixed, paraffin-embedded (FFPE) tissues. 6, 18 The action of formalin results in chemical modifications to RNA that tend to limit the size of transcribable nucleic acid fragments. 10 To compensate for the lability of RNA in FFPE tissues and to increase the amplicon size from that of previously described retrospective CDV studies, 9 a semi-nested protocol was developed and tested on FFPE material. However, the amplicon size for the assay developed here is still short compared with that of reverse transcription polymerase chain reaction (RT-PCR) assays on fresh tissue samples. 6, 15 A semi-nested RT-PCR involves 3 steps of transcription. The first step is the reverse transcription of RNA into singlestranded DNA using the 3Ј oligonucleotide. The second step is the PCR, using the 3Ј oligonucleotide used for reverse transcription and a 5Ј oligonucleotide. This process results in the amplification of the singlestranded DNA into numerous copies of double-stranded DNA. The third step is the semi-nested portion of the reaction. This step utilizes 1 of the original oligonucleotides and a third oligonucleotide in a second round of PCR amplification. A second advantage of nucleic acid-based assays is that nucleic acid sequencing can be used to study the epidemiology of infec-tions by monitoring nucleotide variations. The goal of this study is to test the utility of a semi-nested RT-PCR assay as an additional diagnostic approach for detection of CDV infection.
Materials and methods
Tissue selection and processing. FFPE samples were obtained from case submissions to the Athens Diagnostic Laboratory and the Department of Veterinary Pathology at the College of Veterinary Medicine, University of Georgia, Athens. Autolysis of the samples varied, the maximum length of time in formalin was 72 hr, and the time in the paraffin blocks ranged from 0.5 to 6 yr. Only paraffin blocks containing brain as the sole tissue were used in this study. Test cases were selected from the tissue archive based on a clinical suspicion of CDV infection (dogs 1-8 and 10-12 were from a suspected vaccine failure) and the pathologist's decision that the histologic lesions were compatible with CDV infection. Negative controls consisted of 2 dogs lacking historic and/or microscopic evidence of CDV infection.
Fluorescent antibody test. Immunofluorescent assays were performed on unfixed specimens by staff at the Athens Diagnostic Laboratory at the time of submission. This testing was performed only when requested by the case-coordinating pathologist. Therefore, not all cases have fluorescent antibody (FA) results. Fluorescent antibody testing was performed on frozen tissue using a canine polyclonal anti-CDV antibody. a Histopathology. Histopathologic evaluation was done by examining and grading all sections of hematoxylin and eosin-stained sections of brain tissue (total of 34 slides). Changes in brain tissue that were considered indicative of CDV infection consisted of perivascular cuffing, neuronal necrosis, and the presence of inclusion bodies. The distribution and severity of the lesions was evaluated and then graded accordingly as 0, 1, 2, or 3, with 3 denoting severe diffuse lesions.
Immunohistochemistry. Three-micrometer sections of blocks containing brain tissue were cut onto positively charged slides for immunohistochemistry (IHC). b Viral antigens were retrieved by microwaving slides immersed in citrate buffer. c The slides were then incubated with a mouse monoclonal anti-CDV nucleoprotein antibody d at a dilution of 1:3,000. A secondary biotinylated goat anti-mouse IgG antibody e was applied to samples at a dilution of 1:250, followed by the signal amplification with avidin-biotin-conjugated peroxidase. f The antigen-antibody complex was visualized by its reaction with 3,3Ј-diaminobenzidine. f Slides were counterstained lightly with hematoxylin and coverslipped g for a permanent record.
RNA extraction. The RNA extraction protocol was modified from a previously described method. 9 Each FFPE sample was arbitrarily cut as either a 5-or a 10-m section and placed into sterile microcentrifuge tubes. Sections were then deparaffinized by sequential application of 1 ml of deparaffinizing agent, h agitation of the samples, and centrifugation at 10,000 ϫ g for 10 min. The supernatant was discarded, and the deparaffinization step was repeated. The resultant tissue pellet was washed with 1 ml of cold 100% ethanol and dried for 5-10 min in a vacuum centrifuge. For digestion of proteins and nucleases, the dried sample was incubated at 50 C for 4 hr with 600 l of digestion buffer (0.5 mg/ml proteinase K, i 20 mM Tris-HCl pH 7.6, 20 mM ethylenediaminetetraacetic acid, 1% sodium dodecyl sulfate). To isolate the RNA, 2 phenol/chloroform/isoamyl alcohol extractions were performed, followed by 1 chloroform/isoamyl alcohol extraction. Purified nucleic acid was precipitated with the addition of 1/10 volume of 3 M sodium acetate (pH 7.0), 20 g of glycogen, and a 2ϫ volume of cold 100% ethanol. This solution was incubated at Ϫ20 C overnight. The precipitated nucleic acid was centrifuged at 20,800 ϫ g for 30 min at 4 C, and the pellet was washed with cold 70% ethanol and dried in a vacuum centrifuge for 5-10 min. The pellet was resuspended in 30 l of nuclease-free water and stored at Ϫ20 C. All buffers and reagents were prepared with ribonuclease-free water and plasticware.
RT-PCR. Primers were selected so that the amplicon size was limited to approximately 150 base pairs (bp). The following primers were used: CDV1: 5Ј-AACTGCAGA-GTCTTCCCATC-3Ј antisense primer (bases 285-304); CDV2: 5Ј-GGCGAAGATTATTCCGAAGG-3Ј sense primer (bases 135-154); CDV3: 5Ј-AATGCTTCATCTAACTGG-GG-3Ј internal primer (bases 156-175). The targeted amplification sequence was a 149-bp fragment spanning bases 135-304 of the phosphoprotein gene (Onderstepoort strain M32418). 2 One to 7 l of extracted nucleic acid was added to 14 pmol of primer CDV1. To denature the RNA, the reaction was then incubated for 5 min at 70 C and immediately placed on ice. RNA was reverse transcribed using the following reaction mix: 0.025 mM of each dNTP, i 25 units of RNase inhibitor, i M-MLV reverse transcriptase reaction buffer, 50 units of M-MLV reverse transcriptase, i and nucleasefree water to a total reaction volume of 25 l. The reaction was incubated for 1 hr at 37 C in a thermocycler. j DNA was amplified in a reaction consisting of 25 l reverse transcription product, 2.5 l 10ϫ buffer, 0.5 mM MgCl 2 , 14 pmol primer CDV2, 1.5 units of Taq polymerase, i and nuclease-free water to a total reaction volume of 50 l. The reaction was then incubated in a thermocycler under the following conditions: 94 C/5 min; 35 cycles of 94 C/1 min, 50 C/1 min, 72 C/1 min; and a final extension of 72 C/5 min.
For the second round of PCR, the reaction consisted of 0.2-10 l of first round product to which 10ϫ buffer, 1 mM MgCl 2 , 0.2 mM of each dNTP, 14 pmol primer CDV1, 14 pmol primer CDV3, 1.25 units of Taq polymerase, and nuclease-free water were added for a final volume of 50 l. PCR cycling conditions were identical to those used for the first round.
The amplification products were separated by agarose gel electrophoresis and visualized by staining with ethidium bromide. For 21 FFPE samples (at least 1 FFPE positive sample per positive case, 41 sequences total), bands of the expected molecular weight were excised from gels, and the nucleic acid was extracted. k The extracted DNA fragments were sequenced (Molecular Genetics Instrumentation Facility, University of Georgia), and the results were compared with published data for the CDV phosphoprotein gene. Using a previously described method 9 as a guide, a ␤-actin RT-PCR was developed as a control for the extraction of amplifiable RNA. The reaction was a nonnested RT-PCR and amplified a 177-bp product spanning bases 1464-2081 using the following primers: ␤-actin1: 5Ј-ACAGCCTGGATA-GCAACGTA-3Ј (antisense primer) and ␤-actin2: 5Ј-CGA-CATGGAGAAAATCTGGC-3Ј (sense primer). These primers are based on the human cytoplasmic ␤-actin gene (M10277) 13 and were chosen because they span an intron, which allows for the differentiation between amplicons from an RNA template (177 bp) and a DNA template (618 bp). The ␤-actin RT-PCR protocol was similar to that of the distemper gene protocol with the following exceptions: 1.5 mM MgCl 2 was used, and the cycling parameters were 94 C/5 min; 40 cycles of 94 C/1 min, 50 C/1.5 min, 72 C/1 min; with a final extension of at 72 C/7 min. The product was then visualized and sequenced as previously described. To control for contamination, sections of brain from dogs without signs of viral encephalitis were included in the RNA extraction steps, and a semi-nested RT-PCR was performed that contained only water with the reaction mixture.
Results
Results are presented in Table 1 . All 12 of the test dogs (dogs 1-12) had histologic lesions consistent with a viral encephalitis. Inclusion bodies were noted in 4 of these (dogs 1, 5, 11, 12) . Antigen was detected using the FA assay in 5 (dogs 6-8, 11, 12) of the 10 dogs evaluated. In the remaining 2 dogs, tissues were submitted already in formalin. Immunohistochemical staining was positive in 7 (dogs 1-5, 11, 12) of the 12 dogs. Two of the test dogs were positive by both immunologic (FA and IHC) methods. The 2 negative controls had an absence of inflammatory changes and inclusion bodies and were negative by both FA and IHC.
RNA was successfully extracted from both negative controls and from 11 of the 12 test dogs. A specific CDV product was amplified for 9 of the 12 test dogs. Figure 1 illustrates results of the semi-nested RT-PCR amplifications.
The 41 DNA sequences reported from the samples were aligned, and a consensus sequence was developed (Fig. 2) . This sequence was compared with a consensus sequence derived from 12 pathogenic strains of CDV, a consensus sequence from 4 recently identified Japanese strains of CDV, and a consensus sequence from 2 cell culture-adapted (vaccine) strains (Onderstepoort and Rockborn). The results indicate that the CDV sequence amplified in the present study is more closely related to the non-Japanese pathogenic strains of CDV than to the cell culture-adapted strains (Fig. 2) .
Discussion
The 12 test dogs were selected on the basis of a strong clinical suspicion of CDV infection and the case pathologist's conclusion that the histopathologic changes were most consistent with CDV infection. In the 10 dogs in which both FA and IHC were done, there was agreement in only 3 (dogs 10-12). These conflicting immunologic results may create a conundrum for diagnosis. Although the explanation may be found in geographic sampling, i.e., submission of different parts of the brain for the 2 different tests, the pathologist is still left unsure about a definitive diagnosis.
The variable clinical and pathologic presentations associated with canine distemper make a gross diagnosis challenging. Laboratory-based diagnostic tests have been useful; however, each of these current methods alone has been insufficient in many cases. The addition of a semi-nested RT-PCR assay into the diagnostic arsenal may help to confirm or refute a tentative diagnosis.
This RT-PCR test was done on samples from the same tissue blocks that were used for histopathology and IHC. RT-PCR results were positive in all test dogs except dogs 9 and 10. Dog 9 had minimal histopathologic changes and was negative by IHC testing. Dog 10 did have perivascular cuffing and neuronal necrosis suggesting a viral infection, however, inclusion bodies were not detected by histopathology, and the tissues were negative by IHC and FA testing. Considering all the negative testing for viral antigen or nucleic acid, the lesions in these dogs may not have been caused by the presence of CDV.
An ancillary advantage of the RT-PCR test is the ability to sequence the amplified product. Sequencing provides a means to confirm the presence of CDV nucleic acid by ruling out a misprimed product, thus verifying CDV infection. Moreover, any conserved mutations in the region of the amplified product can be used to provide some insight into the molecular epidemiology of the infection. However, because of formalin fixation the amplicon length is not ideal for sequence analysis. Thus, this assay should not be used for definitive strain definitions but rather as a method to begin retrospective identification of the infecting virus. An example of how this assay can be used in this limited manner was demonstrated in the present study. Several of the dogs that were diagnosed as clinically infected with CDV had been on a routine canine vaccination schedule. The question regarding these dogs centered on determining whether infection was the result of a virulent vaccine or a vaccine failure. Previous epidemiologic data indicated that this outbreak was most likely caused by a vaccine failure and subsequent infection with a wild-type virus (data not shown). The sequence data from all of the test dogs support this original conclusion (Fig. 2) ; the amplified sequence is more closely aligned with the non-Japanese wild-type isolates than with 2 commercially available vaccine strains (Onderstepoort and Rockborn strains).
This RT-PCR test also could be a valuable epidemiologic tool for the detection and monitoring of CDV in wildlife species. In many circumstances, wildlife epizootics are diagnosed based on postmortem testing. This assay would assist in the detection of CDV nucleic acid in these tissues and would help to continually monitor for genetic changes of circulating CDV or for any previously unidentified distemper viruses.
A disadvantage of the semi-nested RT-PCR is the lability of RNA. Thus, the RT-PCR assay requires prompt but limited fixation of tissue samples in formalin and careful handling of specimens to prevent contamination with RNase. Although RT-PCR assays can be utilized with a variety of tissue types, the type of tissue fixation (if any) has a bearing on the design of the assay. Tissue that is fresh must be processed immediately because endogenous RNase activity will severely decrease the amount of intact RNA in the specimen. It is important to limit the fixation time because the fixation process results in chemical modifications to the RNA that impair reverse transcription. 9, 10 Even with proper formalin fixation, the size of the desired amplification product should be limited because the percentage of false-negative results increases as the size of the amplicon increases. 9, 20 This size limitation is why a semi-nested RT-PCR assay was chosen for this study. To use a fully nested technique, the size of the first round amplicon would have to be at least 20 bp larger. During this study, several blocks did not yield amplifiable RNA, even though some contained severe lesions (e.g., dog 12). This result highlights the need for multiple blocks per animal and emphasizes the limitations imposed on RNA extraction by formalin fixation. Other disadvantages of the semi-nested RT-PCR assay are the amount of time required and the lack of quantitative results.
The RT-PCR assay is a valuable adjunct technique for the diagnosis of CDV infection and was very useful in cases of conflicting immunologic results. When combined with genetic sequencing, this assay also allows retrospective epidemiologic tracking. j. GeneAmp 2400, PE Biosystems, Foster City, CA. k. QiaQuick Gel Extraction kit, Qiagen, Valencia, CA.
